NCT06396962View on ClinicalTrials.gov

Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience

CompletedOBSERVATIONAL

Enrollment

110

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

April 29, 2024

Study Completion Date

April 29, 2024

Conditions

Primary Retroperitoneal Sarcoma

Interventions

OTHER

WANG DAORONG

surgery

Trial Locations (1)

225001

Northern Jiangsu People's Hospital, Yangzhou

All Listed Sponsors

lead

Northern Jiangsu People's Hospital

OTHER

NCT06396962 - Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience | Biotech Hunter | Biotech Hunter